STEPHANIE DU: Open Payments
NPI 1508645755 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 16 payments from 11 companies in 2025. Trend: 2023 $683 · 2024 $1,203 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK NRO, Inc. | 2 | $184 |
| Merck Sharp & Dohme LLC | 3 | $91 |
| SOBI, INC | 2 | $72 |
| Incyte Corporation | 2 | $36 |
| Aveo Pharmaceuticals, Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| PharmaEssentia USA Corporation | 1 | $24 |
Products named: Prospera, KEYTRUDA, Vonjo, JAKAFI, FOTIVDA, CALQUENCE, Fabhalta, Enhertu.
Industry payments across TX — which companies pay providers there.
